{"transactions":[{"id":1069808,"issuer":{"id":8714,"kind":"organization","name":"Vicarious Surgical Inc."},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-08-11T21:01:48.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":297600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest as to 25% of the award on August 7, 2026, with the remainder vesting in equal monthly installments over the following 36 months, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":297600,"derivative":{"exercise_price":8.92,"expiration_date":"2035-08-06","underlying":"Class A Common Stock","underlying_shares":297600},"source":{"system":"sec-edgar","filing":"0001213900-25-074538","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620137/000121390025074538/ownership.xml","form_type":"4"}},{"id":2441287,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2022-01-06T22:10:17.000Z","date":"2022-01-05","kind":"tax_withholding","acquired":false,"shares":326,"price":1.08,"value":352.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 01/01/2022."}],"balance_after":67693,"source":{"system":"sec-edgar","filing":"0001104659-22-001942","document":"tm222161-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465922001942/tm222161-1_4seq1.xml","form_type":"4"}},{"id":2480263,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2021-12-08T21:16:32.000Z","date":"2021-12-07","kind":"tax_withholding","acquired":false,"shares":273,"price":1.3,"value":354.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 12/01/2021."}],"balance_after":68019,"source":{"system":"sec-edgar","filing":"0001104659-21-147638","document":"tm2134911d2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921147638/tm2134911d2_4seq1.xml","form_type":"4"}},{"id":2525827,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2021-11-03T20:16:21.000Z","date":"2021-11-02","kind":"tax_withholding","acquired":false,"shares":250,"price":1.98,"value":495.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 11/01/2021."}],"balance_after":68292,"source":{"system":"sec-edgar","filing":"0001104659-21-133655","document":"tm2131814-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921133655/tm2131814-3_4seq1.xml","form_type":"4"}},{"id":2548248,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2021-10-05T22:39:48.000Z","date":"2021-10-04","kind":"tax_withholding","acquired":false,"shares":249,"price":2.01,"value":500.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 10/01/2021."}],"balance_after":68542,"source":{"system":"sec-edgar","filing":"0001104659-21-123265","document":"tm2129310d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921123265/tm2129310d1_4seq1.xml","form_type":"4"}},{"id":2578650,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2021-09-03T20:17:20.000Z","date":"2021-09-02","kind":"tax_withholding","acquired":false,"shares":253,"price":1.81,"value":457.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 09/01/2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.81, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":68791,"source":{"system":"sec-edgar","filing":"0001104659-21-112942","document":"tm2126978-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921112942/tm2126978-3_4seq1.xml","form_type":"4"}},{"id":2614402,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2021-08-04T21:46:35.000Z","date":"2021-08-03","kind":"tax_withholding","acquired":false,"shares":261,"price":2.4,"value":626.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 08/01/2021."}],"balance_after":69044,"source":{"system":"sec-edgar","filing":"0001104659-21-100200","document":"tm2124160d4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921100200/tm2124160d4_4seq1.xml","form_type":"4"}},{"id":2640682,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2021-07-06T20:31:12.000Z","date":"2021-07-02","kind":"tax_withholding","acquired":false,"shares":877,"price":3.7,"value":3244.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 07/01/2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $3.75, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":69305,"source":{"system":"sec-edgar","filing":"0001104659-21-089442","document":"tm2121558d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921089442/tm2121558d1_4.xml","form_type":"4"}},{"id":2678922,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2021-06-07T21:02:27.000Z","date":"2021-06-04","kind":"tax_withholding","acquired":false,"shares":878,"price":4.19,"value":3678.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 06/01/2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.19 to $4.39, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":70182,"source":{"system":"sec-edgar","filing":"0001104659-21-077766","document":"tm2119042d4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921077766/tm2119042d4_4seq1.xml","form_type":"4"}},{"id":2726654,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2021-05-06T01:57:54.000Z","date":"2021-05-04","kind":"tax_withholding","acquired":false,"shares":889,"price":4.13,"value":3671.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 05/01/2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.13 to $4.48, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":71060,"source":{"system":"sec-edgar","filing":"0001104659-21-061950","document":"tm2115347d4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921061950/tm2115347d4_4.xml","form_type":"4"}},{"id":2751952,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2021-04-09T20:16:26.000Z","date":"2021-04-08","kind":"tax_withholding","acquired":false,"shares":899,"price":4.94,"value":4441.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 04/01/2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 to $4.94, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":71949,"source":{"system":"sec-edgar","filing":"0001104659-21-048716","document":"tm2112624-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921048716/tm2112624-4_4seq1.xml","form_type":"4"}},{"id":2805445,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2021-03-05T21:31:42.000Z","date":"2021-03-03","kind":"tax_withholding","acquired":false,"shares":898,"price":5.46,"value":4903.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 03/01/2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.46 to $5.51, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":72848,"source":{"system":"sec-edgar","filing":"0001104659-21-032768","document":"tm218853-4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921032768/tm218853-4_4.xml","form_type":"4"}},{"id":2880999,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-04T02:53:27.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2022, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":10000,"derivative":{"exercise_price":6.46,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-21-011851","document":"tm215262-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921011851/tm215262-9_4seq1.xml","form_type":"4"}},{"id":2880998,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2021-02-04T02:53:27.000Z","date":"2021-02-02","kind":"tax_withholding","acquired":false,"shares":3542,"price":6.34,"value":22456.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 02/01/2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.34 to $6.42, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":73746,"source":{"system":"sec-edgar","filing":"0001104659-21-011851","document":"tm215262-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921011851/tm215262-9_4seq1.xml","form_type":"4"}},{"id":2919275,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-05T21:17:17.000Z","date":"2021-01-04","kind":"tax_withholding","acquired":false,"shares":705,"price":4.85,"value":3419.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 01/01/2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.85 to $4.88, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":77288,"source":{"system":"sec-edgar","filing":"0001104659-21-000935","document":"tm211689-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921000935/tm211689-4_4seq1.xml","form_type":"4"}},{"id":2953123,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-09T01:17:25.000Z","date":"2020-12-07","kind":"tax_withholding","acquired":false,"shares":588,"price":3.76,"value":2210.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 12/01/2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.76 to $3.80, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":77993,"source":{"system":"sec-edgar","filing":"0001104659-20-133325","document":"tm2038041-3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920133325/tm2038041-3_4.xml","form_type":"4"}},{"id":2994331,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-11-03T21:16:11.000Z","date":"2020-11-02","kind":"tax_withholding","acquired":false,"shares":623,"price":3.51,"value":2186.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 11/01/2020."}],"balance_after":78581,"source":{"system":"sec-edgar","filing":"0001104659-20-120955","document":"tm2034888d4_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920120955/tm2034888d4_form4.xml","form_type":"4"}},{"id":3012627,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-10-05T21:57:55.000Z","date":"2020-10-02","kind":"tax_withholding","acquired":false,"shares":631,"price":3.88,"value":2448.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 10/01/2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.88 to $3.94, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":79204,"source":{"system":"sec-edgar","filing":"0001104659-20-112303","document":"tm2032523-4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920112303/tm2032523-4_4.xml","form_type":"4"}},{"id":3038722,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-09-03T21:31:27.000Z","date":"2020-09-02","kind":"tax_withholding","acquired":false,"shares":628,"price":3.94,"value":2474.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 09/01/2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.93 to $3.94, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":79835,"source":{"system":"sec-edgar","filing":"0001104659-20-102300","document":"tm2030216d4_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920102300/tm2030216d4_form4.xml","form_type":"4"}},{"id":3066985,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-08-05T21:12:12.000Z","date":"2020-08-04","kind":"tax_withholding","acquired":false,"shares":615,"price":4.11,"value":2527.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 08/01/2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.11 to $4.12, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":80463,"source":{"system":"sec-edgar","filing":"0001104659-20-090919","document":"tm2026743-3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920090919/tm2026743-3_4.xml","form_type":"4"}},{"id":3088338,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-07-06T20:16:29.000Z","date":"2020-07-02","kind":"tax_withholding","acquired":false,"shares":625,"price":4.82,"value":3012.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 07/01/2020."}],"balance_after":81078,"source":{"system":"sec-edgar","filing":"0001104659-20-081227","document":"tm2024119-4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920081227/tm2024119-4_4.xml","form_type":"4"}},{"id":3121743,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-06-04T20:18:16.000Z","date":"2020-06-03","kind":"tax_withholding","acquired":false,"shares":627,"price":5.11,"value":3203.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 06/01/2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.11 to $5.2202, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":81703,"source":{"system":"sec-edgar","filing":"0001104659-20-069826","document":"tm2021837-4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920069826/tm2021837-4_4.xml","form_type":"4"}},{"id":3159200,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-06T20:30:26.000Z","date":"2020-05-05","kind":"tax_withholding","acquired":false,"shares":617,"price":5.1,"value":3146.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 05/01/2020."}],"balance_after":82330,"source":{"system":"sec-edgar","filing":"0001104659-20-057468","document":"tm2018856d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920057468/tm2018856d1_4.xml","form_type":"4"}},{"id":3182610,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-04-03T21:55:54.000Z","date":"2020-04-02","kind":"tax_withholding","acquired":false,"shares":670,"price":4.97,"value":3329.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 04/01/2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.96 to $5.12, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":82947,"source":{"system":"sec-edgar","filing":"0001104659-20-043263","document":"tm2014998d3_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920043263/tm2014998d3_form4.xml","form_type":"4"}},{"id":3217261,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-03-10T23:13:33.000Z","date":"2020-03-09","kind":"tax_withholding","acquired":false,"shares":712,"price":5,"value":3560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 03/01/2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.05, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":83617,"source":{"system":"sec-edgar","filing":"0001104659-20-031499","document":"tm2012338d4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920031499/tm2012338d4_4.xml","form_type":"4"}},{"id":3262319,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-19T21:32:58.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2021, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":30000,"derivative":{"exercise_price":6.55,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-20-022849","document":"tm209305-9_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920022849/tm209305-9_4.xml","form_type":"4"}},{"id":3262318,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-19T21:32:58.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). The restrictions will vest as to one-third (1/3) of the shares on February 1, 2021, and the remaining balance will vest monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":84329,"source":{"system":"sec-edgar","filing":"0001104659-20-022849","document":"tm209305-9_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920022849/tm209305-9_4.xml","form_type":"4"}},{"id":3288238,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-05T22:09:56.000Z","date":"2020-02-04","kind":"tax_withholding","acquired":false,"shares":584,"price":6,"value":3504.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 02/01/2020."}],"balance_after":64329,"source":{"system":"sec-edgar","filing":"0001104659-20-011342","document":"tm206871d4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920011342/tm206871d4_4.xml","form_type":"4"}},{"id":3317712,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-01-06T22:48:32.000Z","date":"2020-01-03","kind":"tax_withholding","acquired":false,"shares":730,"price":9.52,"value":6949.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 01/01/2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.395 to $9.52, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":64913,"source":{"system":"sec-edgar","filing":"0001104659-20-001639","document":"tm201302-4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920001639/tm201302-4_4.xml","form_type":"4"}},{"id":3333686,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-20T22:27:25.000Z","date":"2019-12-18","kind":"tax_withholding","acquired":false,"shares":653,"price":7.46,"value":4871.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 12/01/2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.46 to $7.48, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":65643,"source":{"system":"sec-edgar","filing":"0001104659-19-075128","document":"tm1926709d1_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465919075128/tm1926709d1_form4.xml","form_type":"4"}},{"id":3377396,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-11-07T21:15:44.000Z","date":"2019-11-05","kind":"tax_withholding","acquired":false,"shares":670,"price":3.85,"value":2579.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 11/01/2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.85 to $4.00, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":66296,"source":{"system":"sec-edgar","filing":"0001104659-19-061122","document":"tm1922166-2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465919061122/tm1922166-2_4.xml","form_type":"4"}},{"id":3394283,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-10-11T20:06:05.000Z","date":"2019-10-09","kind":"tax_withholding","acquired":false,"shares":1184,"price":2.95,"value":3492.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 09/01/2019 and 10/01/2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.89 to $3.02, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Effective as of 08/30/2019, the Issuer effected a 1-for-15 reverse split of its common stock. The number of shares reflects the reverse stock split."}],"balance_after":66966,"source":{"system":"sec-edgar","filing":"0001144204-19-048122","document":"tv530955_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420419048122/tv530955_4.xml","form_type":"4"}},{"id":3444366,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-07T23:21:54.000Z","date":"2019-08-06","kind":"tax_withholding","acquired":false,"shares":10206,"price":0.21,"value":2143.26,"ownership":{"direct":true},"balance_after":1022259,"source":{"system":"sec-edgar","filing":"0001144204-19-038335","document":"tv527078_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420419038335/tv527078_4.xml","form_type":"4"}},{"id":3461779,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-07-16T00:37:54.000Z","date":"2019-07-15","kind":"sale","acquired":false,"shares":42452,"price":0.233,"value":9891.316,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 07/10/2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.227 to $0.2403, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4."}],"balance_after":1032465,"source":{"system":"sec-edgar","filing":"0001144204-19-034763","document":"tv525229_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420419034763/tv525229_4.xml","form_type":"4"}},{"id":3461778,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-07-16T00:37:54.000Z","date":"2019-07-12","kind":"sale","acquired":false,"shares":42452,"price":0.2356,"value":10001.6912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 07/10/2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.2257 to $0.24, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4."}],"balance_after":1074917,"source":{"system":"sec-edgar","filing":"0001144204-19-034763","document":"tv525229_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420419034763/tv525229_4.xml","form_type":"4"}},{"id":3461777,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-07-16T00:37:54.000Z","date":"2019-07-11","kind":"sale","acquired":false,"shares":42451,"price":0.2406,"value":10213.7106,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares to cover taxes due on restricted stock that vested on 07/10/2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.24 to $0.245, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":1117369,"source":{"system":"sec-edgar","filing":"0001144204-19-034763","document":"tv525229_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420419034763/tv525229_4.xml","form_type":"4"}},{"id":3673729,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-05T21:37:01.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2020, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":200000,"derivative":{"exercise_price":0.48,"expiration_date":"2029-02-01","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001144204-19-005043","document":"tv512443_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420419005043/tv512443_form4.xml","form_type":"4"}},{"id":3868487,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-07-12T21:00:27.000Z","date":"2018-07-10","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The restrictions will vest as to one-third (1/3) of the shares on July 10, 2019, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":1159820,"source":{"system":"sec-edgar","filing":"0001144204-18-038190","document":"tv498481_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420418038190/tv498481_4.xml","form_type":"4"}},{"id":3960800,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Warrants (right to buy)","published_at":"2018-04-18T21:23:46.000Z","date":"2018-04-17","kind":"purchase","acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased by the reporting person for a combined purchase price of $0.32 per share of common stock and warrant in connection with the Issuer's public offering that closed on April 17, 2018. Each warrant will be exercisable during the period commencing on April 17, 2018 and ending on April 17, 2023 at an exercise price of $0.32."}],"balance_after":125000,"derivative":{"exercise_price":0.32,"exercise_date":"2018-04-17","expiration_date":"2023-04-17","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001144204-18-021206","document":"tv491363_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420418021206/tv491363_4.xml","form_type":"4"}},{"id":3960799,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-04-18T21:23:46.000Z","date":"2018-04-17","kind":"purchase","acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased by the reporting person for a combined purchase price of $0.32 per share of common stock and warrant in connection with the Issuer's public offering that closed on April 17, 2018. Each warrant will be exercisable during the period commencing on April 17, 2018 and ending on April 17, 2023 at an exercise price of $0.32."}],"balance_after":409820,"source":{"system":"sec-edgar","filing":"0001144204-18-021206","document":"tv491363_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420418021206/tv491363_4.xml","form_type":"4"}},{"id":4023319,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-01T21:11:19.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 28, 2019, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":150000,"derivative":{"exercise_price":0.57,"expiration_date":"2028-02-28","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001144204-18-012234","document":"tv487514_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420418012234/tv487514_4.xml","form_type":"4"}},{"id":4110685,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-01-03T21:05:19.000Z","date":"2017-12-29","kind":"other","acquired":true,"shares":12355,"price":1.01,"value":12478.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Issuer's Employee Stock Purchase Plan on December 29, 2017 in a transaction exempt under Rule 16b-3(c)."}],"balance_after":284820,"source":{"system":"sec-edgar","filing":"0001144204-18-000492","document":"tv482535_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420418000492/tv482535_4.xml","form_type":"4"}},{"id":4237609,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-08-10T21:57:57.000Z","date":"2017-08-10","kind":"purchase","acquired":true,"shares":12500,"price":1.03,"value":12875.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9901 to $1.03, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":272465,"source":{"system":"sec-edgar","filing":"0001144204-17-042118","document":"v473009_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420417042118/v473009_4.xml","form_type":"4"}},{"id":4274301,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2017-06-22T20:22:27.000Z","date":"2017-06-21","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on June 21, 2018, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":125000,"derivative":{"exercise_price":1.35,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001144204-17-033630","document":"v469455_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420417033630/v469455_4.xml","form_type":"4"}},{"id":4281955,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Warrants (right to buy)","published_at":"2017-06-14T20:50:20.000Z","date":"2017-06-14","kind":"purchase","acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased by the reporting person for a combined purchase price of $1.50 per share of common stock and warrant in connection with the Issuer's public offering that closed on June 14, 2017.  Each warrant will be exercisable during the period commencing on June 14, 2017 and ending on June 14, 2022 at an exercise price of $1.50."}],"balance_after":60000,"derivative":{"exercise_price":1.5,"exercise_date":"2017-06-14","expiration_date":"2022-06-14","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001144204-17-032552","document":"v469021_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420417032552/v469021_form4.xml","form_type":"4"}},{"id":4281954,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-06-14T20:50:20.000Z","date":"2017-06-14","kind":"purchase","acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased by the reporting person for a combined purchase price of $1.50 per share of common stock and warrant in connection with the Issuer's public offering that closed on June 14, 2017.  Each warrant will be exercisable during the period commencing on June 14, 2017 and ending on June 14, 2022 at an exercise price of $1.50."}],"balance_after":259965,"source":{"system":"sec-edgar","filing":"0001144204-17-032552","document":"v469021_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420417032552/v469021_form4.xml","form_type":"4"}},{"id":4309879,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2017-05-22T20:19:32.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option became exercisable immediately upon grant."}],"balance_after":25000,"derivative":{"exercise_price":1.8,"expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001144204-17-028874","document":"v467586_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420417028874/v467586_4.xml","form_type":"4"}},{"id":4463688,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-02-07T21:15:30.000Z","date":"2017-02-06","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan.  The restrictions will vest as to one-third (1/3) of the shares on February 6, 2018, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":199965,"source":{"system":"sec-edgar","filing":"0001144204-17-006500","document":"v458598_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420417006500/v458598_4.xml","form_type":"4"}},{"id":4601279,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":76694,"kind":"person","name":"FROM STEPHEN","position":1,"cik":"0001620137","reported_name":"FROM STEPHEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-09-16T20:15:24.000Z","date":"2016-09-15","kind":"purchase","acquired":true,"shares":15000,"price":1.4892,"value":22338.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.479 to $1.509, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":139965,"source":{"system":"sec-edgar","filing":"0001144204-16-124265","document":"v448959_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420416124265/v448959_4.xml","form_type":"4"}}]}